The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease. / Sørensen, Ida MH; Bisgaard, Line S.; Bjergfelt, Sasha S.; Ballegaard, Ellen LF; Biering-Sørensen, Tor; Landler, Nino E.; Pedersen, Tanja X.; Kofoed, Klaus F.; Lange, Theis; Feldt-Rasmussen, Bo; Bro, Susanne; Christoffersen, Christina.

I: Atherosclerosis, Bind 350, 2022, s. 109-118.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Sørensen, IMH, Bisgaard, LS, Bjergfelt, SS, Ballegaard, ELF, Biering-Sørensen, T, Landler, NE, Pedersen, TX, Kofoed, KF, Lange, T, Feldt-Rasmussen, B, Bro, S & Christoffersen, C 2022, 'The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease', Atherosclerosis, bind 350, s. 109-118. https://doi.org/10.1016/j.atherosclerosis.2022.03.019

APA

Sørensen, I. MH., Bisgaard, L. S., Bjergfelt, S. S., Ballegaard, E. LF., Biering-Sørensen, T., Landler, N. E., Pedersen, T. X., Kofoed, K. F., Lange, T., Feldt-Rasmussen, B., Bro, S., & Christoffersen, C. (2022). The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease. Atherosclerosis, 350, 109-118. https://doi.org/10.1016/j.atherosclerosis.2022.03.019

Vancouver

Sørensen IMH, Bisgaard LS, Bjergfelt SS, Ballegaard ELF, Biering-Sørensen T, Landler NE o.a. The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease. Atherosclerosis. 2022;350:109-118. https://doi.org/10.1016/j.atherosclerosis.2022.03.019

Author

Sørensen, Ida MH ; Bisgaard, Line S. ; Bjergfelt, Sasha S. ; Ballegaard, Ellen LF ; Biering-Sørensen, Tor ; Landler, Nino E. ; Pedersen, Tanja X. ; Kofoed, Klaus F. ; Lange, Theis ; Feldt-Rasmussen, Bo ; Bro, Susanne ; Christoffersen, Christina. / The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease. I: Atherosclerosis. 2022 ; Bind 350. s. 109-118.

Bibtex

@article{70108f9b6eb44cc0b749b91d59c2ca58,
title = "The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease",
abstract = "Background and aims: The relationship between chronic kidney disease (CKD) and cardiovascular events is well-established. Clinically recognised risk factors of cardiovascular disease cannot fully explain this association. The objective of the present cross-sectional study was to investigate associations between serum metabolites and prevalent cardiovascular disease, as well as subclinical cardiovascular disease measured as coronary artery calcium score (CACS) in patients with CKD. Methods: More than 200 preselected metabolites were quantified using nuclear magnetic resonance spectroscopy in 725 patients and 174 controls from the Copenhagen CKD Cohort. CACS was determined by computed tomography. Results: Mean age of patients was 57.8 years, and 444 (61.3%) were men. Most of patients had hypercholesterolemia, and 133 (18.3%) had type 2 diabetes. Overall, 85 metabolites were significantly associated with prevalent cardiovascular disease in a model adjusted for eGFR, age, and sex, as well as Bonferroni correction for multiple testing (p < 0.001). After further adjusting for diabetes, BMI, smoking, and cholesterol-lowering medication, the significance was lost for all but six metabolites (concentration of ApoA-1, cholesterol in total HDL and HDL2, total lipids and phospholipids in large HDL particles, and the ratio of phospholipids to total lipids in smaller VLDL particles). Of the 85 metabolites associated with prevalent cardiovascular disease, 71 were also associated with CACS in a similar pattern. Yet, in the model adjusted for all seven cardiovascular risk factors, only serum glucose levels and the ratio of triglycerides to total lipids in larger LDL particles remained significant. Conclusions: In patients with CKD, associations with prevalent cardiovascular disease were mainly found for HDL-related metabolites, while CACS was associated with glucose levels and increased triglycerides to total lipids ratio in LDL particles.",
keywords = "Cardiovascular disease, CKD, Coronary calcification, Metabolomics, NMR",
author = "S{\o}rensen, {Ida MH} and Bisgaard, {Line S.} and Bjergfelt, {Sasha S.} and Ballegaard, {Ellen LF} and Tor Biering-S{\o}rensen and Landler, {Nino E.} and Pedersen, {Tanja X.} and Kofoed, {Klaus F.} and Theis Lange and Bo Feldt-Rasmussen and Susanne Bro and Christina Christoffersen",
note = "Publisher Copyright: {\textcopyright} 2022 Elsevier B.V.",
year = "2022",
doi = "10.1016/j.atherosclerosis.2022.03.019",
language = "English",
volume = "350",
pages = "109--118",
journal = "Journal of atherosclerosis research",
issn = "1567-5688",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease

AU - Sørensen, Ida MH

AU - Bisgaard, Line S.

AU - Bjergfelt, Sasha S.

AU - Ballegaard, Ellen LF

AU - Biering-Sørensen, Tor

AU - Landler, Nino E.

AU - Pedersen, Tanja X.

AU - Kofoed, Klaus F.

AU - Lange, Theis

AU - Feldt-Rasmussen, Bo

AU - Bro, Susanne

AU - Christoffersen, Christina

N1 - Publisher Copyright: © 2022 Elsevier B.V.

PY - 2022

Y1 - 2022

N2 - Background and aims: The relationship between chronic kidney disease (CKD) and cardiovascular events is well-established. Clinically recognised risk factors of cardiovascular disease cannot fully explain this association. The objective of the present cross-sectional study was to investigate associations between serum metabolites and prevalent cardiovascular disease, as well as subclinical cardiovascular disease measured as coronary artery calcium score (CACS) in patients with CKD. Methods: More than 200 preselected metabolites were quantified using nuclear magnetic resonance spectroscopy in 725 patients and 174 controls from the Copenhagen CKD Cohort. CACS was determined by computed tomography. Results: Mean age of patients was 57.8 years, and 444 (61.3%) were men. Most of patients had hypercholesterolemia, and 133 (18.3%) had type 2 diabetes. Overall, 85 metabolites were significantly associated with prevalent cardiovascular disease in a model adjusted for eGFR, age, and sex, as well as Bonferroni correction for multiple testing (p < 0.001). After further adjusting for diabetes, BMI, smoking, and cholesterol-lowering medication, the significance was lost for all but six metabolites (concentration of ApoA-1, cholesterol in total HDL and HDL2, total lipids and phospholipids in large HDL particles, and the ratio of phospholipids to total lipids in smaller VLDL particles). Of the 85 metabolites associated with prevalent cardiovascular disease, 71 were also associated with CACS in a similar pattern. Yet, in the model adjusted for all seven cardiovascular risk factors, only serum glucose levels and the ratio of triglycerides to total lipids in larger LDL particles remained significant. Conclusions: In patients with CKD, associations with prevalent cardiovascular disease were mainly found for HDL-related metabolites, while CACS was associated with glucose levels and increased triglycerides to total lipids ratio in LDL particles.

AB - Background and aims: The relationship between chronic kidney disease (CKD) and cardiovascular events is well-established. Clinically recognised risk factors of cardiovascular disease cannot fully explain this association. The objective of the present cross-sectional study was to investigate associations between serum metabolites and prevalent cardiovascular disease, as well as subclinical cardiovascular disease measured as coronary artery calcium score (CACS) in patients with CKD. Methods: More than 200 preselected metabolites were quantified using nuclear magnetic resonance spectroscopy in 725 patients and 174 controls from the Copenhagen CKD Cohort. CACS was determined by computed tomography. Results: Mean age of patients was 57.8 years, and 444 (61.3%) were men. Most of patients had hypercholesterolemia, and 133 (18.3%) had type 2 diabetes. Overall, 85 metabolites were significantly associated with prevalent cardiovascular disease in a model adjusted for eGFR, age, and sex, as well as Bonferroni correction for multiple testing (p < 0.001). After further adjusting for diabetes, BMI, smoking, and cholesterol-lowering medication, the significance was lost for all but six metabolites (concentration of ApoA-1, cholesterol in total HDL and HDL2, total lipids and phospholipids in large HDL particles, and the ratio of phospholipids to total lipids in smaller VLDL particles). Of the 85 metabolites associated with prevalent cardiovascular disease, 71 were also associated with CACS in a similar pattern. Yet, in the model adjusted for all seven cardiovascular risk factors, only serum glucose levels and the ratio of triglycerides to total lipids in larger LDL particles remained significant. Conclusions: In patients with CKD, associations with prevalent cardiovascular disease were mainly found for HDL-related metabolites, while CACS was associated with glucose levels and increased triglycerides to total lipids ratio in LDL particles.

KW - Cardiovascular disease

KW - CKD

KW - Coronary calcification

KW - Metabolomics

KW - NMR

U2 - 10.1016/j.atherosclerosis.2022.03.019

DO - 10.1016/j.atherosclerosis.2022.03.019

M3 - Journal article

C2 - 35339279

AN - SCOPUS:85127616781

VL - 350

SP - 109

EP - 118

JO - Journal of atherosclerosis research

JF - Journal of atherosclerosis research

SN - 1567-5688

ER -

ID: 311145303